Skin-cancer vaccine shows promise; America’s government debt passes $40trn, and more

The World in Brief from The Economist by The Economist

Moderna and Merck, two American pharma companies, reported successful interim results in the trial of a personalised skin-cancer vaccine. Hosted on Acast. See acast.com/privacy for more information.